{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:23:54Z","timestamp":1791559434829,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,30]]},"DOI":"10.7759\/cureus.113682","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:50:49Z","timestamp":1785444649000},"source":"Crossref","is-referenced-by-count":1,"title":["Suspected Lamotrigine-Associated Haematological Adverse Reaction in the Context of Polypharmacy, Alcohol Use, HIV, and Recent Medication Changes"],"prefix":"10.7759","author":[{"given":"Tolulope","family":"Alabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Lamotrigine. (2026). Accessed. July 16, 2026: https:\/\/bnf.nice.org.uk\/drugs\/lamotrigine\/."},{"key":"ref2","unstructured":"Lamictal tablets. (2025). Accessed. July 16, 2026: https:\/\/www.medicines.org.uk\/emc\/product\/8052\/smpc."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119844199","article-title":"Lamotrigine augmentation in treatment-resistant unipolar depression: a comprehensive meta-analysis of efficacy and safety","volume":"33","author":"Goh KK","year":"2019","unstructured":"Goh KK, Chen CH, Chiu YH, Lu ML. Lamotrigine augmentation in treatment-resistant unipolar depression: a comprehensive meta-analysis of efficacy and safety. J Psychopharmacol. 2019, 33:700-13. 10.1177\/0269881119844199","journal-title":"J Psychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211045870","article-title":"Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review","volume":"11","author":"Besag FM","year":"2021","unstructured":"Besag FM, Vasey MJ, Sharma AN, Lam IC. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol. 2021, 11:20451253211045870. 10.1177\/20451253211045870","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5136","article-title":"Lamotrigine-induced neutropenia after high-dose concomitant initiation with phenytoin","volume":"9","author":"Salem M","year":"2021","unstructured":"Salem M, El-Bardissy A. Lamotrigine-induced neutropenia after high-dose concomitant initiation with phenytoin. Clin Case Rep. 2021, 9:e05136. 10.1002\/ccr3.5136","journal-title":"Clin Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics","volume":"30","author":"Mitra-Ghosh T","year":"2020","unstructured":"Mitra-Ghosh T, Callisto SP, Lamba JK, et al.. PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2020, 30:81-90. 10.1097\/FPC.0000000000000397","journal-title":"Pharmacogenet Genomics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7192.1179a","article-title":"Agranulocytosis associated with lamotrigine","volume":"318","author":"de Camargo OA","year":"1999","unstructured":"de Camargo OA, Bode H. Agranulocytosis associated with lamotrigine. BMJ. 1999, 318:1179. 10.1136\/bmj.318.7192.1179a","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.07.010","article-title":"Comorbidity of Stevens-Johnson syndrome and neutropenia associated with lamotrigine: a case report","volume":"36","author":"Yasui-Furukori N","year":"2014","unstructured":"Yasui-Furukori N, Hashimoto K, Tsuruga K, Nakamura K. Comorbidity of Stevens-Johnson syndrome and neutropenia associated with lamotrigine: a case report. Gen Hosp Psychiatry. 2014, 36:761.e9-11. 10.1016\/j.genhosppsych.2014.07.010","journal-title":"Gen Hosp Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos PN","year":"2003","unstructured":"Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2003, 2:473-81. 10.1016\/S1474-4422(03)00483-6","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol15.15798","article-title":"Lamotrigine drug interactions: ignorance is not bliss","volume":"15","author":"Armstrong AG","year":"2022","unstructured":"Armstrong AG, Kalia R, Troutman M. Lamotrigine drug interactions: ignorance is not bliss. Kans J Med. 2022, 15:109-11. 10.17161\/kjm.vol15.15798","journal-title":"Kans J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.11.033","article-title":"Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder","volume":"30","author":"Chang CC","year":"2006","unstructured":"Chang CC, Shiah IS, Yeh CB, Wang TS, Chang HA. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006, 30:741-4. 10.1016\/j.pnpbp.2005.11.033","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200011000-00014","article-title":"Lamotrigine-associated neutropenia in a geriatric patient","volume":"8","author":"Damiani JT","year":"2000","unstructured":"Damiani JT, Christensen RC. Lamotrigine-associated neutropenia in a geriatric patient. Am J Geriatr Psychiatry. 2000, 8:346. 10.1097\/00019442-200011000-00014","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160991","article-title":"Antidepressant discontinuation syndrome","volume":"189","author":"Gabriel M","year":"2017","unstructured":"Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017, 189:E747. 10.1503\/cmaj.160991","journal-title":"CMAJ"},{"key":"ref14","unstructured":"Duloxetine. (2025). Accessed. July 16, 2026: https:\/\/bnf.nice.org.uk\/drugs\/duloxetine\/."},{"key":"ref15","unstructured":"Cymbalta (duloxetine). (2025). Accessed. July 16, 2026: https:\/\/www.medicines.org.uk\/emc\/product\/3880\/smpc."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2020.02.166","article-title":"Alcohol-induced thrombocytopenia: current review","volume":"86","author":"Silczuk A","year":"2020","unstructured":"Silczuk A, Habrat B. Alcohol-induced thrombocytopenia: current review. Alcohol. 2020, 86:9-16. 10.1016\/j.alcohol.2020.02.166","journal-title":"Alcohol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2326-9-5","article-title":"Profile of hematological abnormalities of Indian HIV infected individuals","volume":"9","author":"Dikshit B","year":"2009","unstructured":"Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord. 2009, 9:5. 10.1186\/1471-2326-9-5","journal-title":"BMC Blood Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518031-suspected-lamotrigine-associated-haematological-adverse-reaction-in-the-context-of-polypharmacy-alcohol-use-hiv-and-recent-medication-changes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:50:50Z","timestamp":1785444650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518031-suspected-lamotrigine-associated-haematological-adverse-reaction-in-the-context-of-polypharmacy-alcohol-use-hiv-and-recent-medication-changes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.113682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}